Artwork

Kandungan disediakan oleh The China-Global South Project. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The China-Global South Project atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

China's High-Risk, High-Reward C19 Vaccine Diplomacy in Africa

49:56
 
Kongsi
 

Manage episode 274340056 series 2776077
Kandungan disediakan oleh The China-Global South Project. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The China-Global South Project atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Last May, Chinese President Xi Jinping announced that Beijing would make any future COVID-19 vaccine available to Africa and other developing regions as a "global public good." He didn't explain, though, what that actually meant. Since that speech to the World Health Assembly, there've been very few details as to how China plans to distribute a C19 vaccine in Africa, how much it will cost and which countries will have to pay for it.

But last week we got our first clue as to what the Chinese may be planning to do. After months of hesitation, Chinese Foreign Ministry spokeswoman Hua Chunyin delivered a surprise announcement last Friday that the government will join the COVID-19 global vaccine alliance known as Covax. This is the same organization that the U.S. has refused to support due to its close relationship with the World Health Organization that Washington recently withdrew from and that it contends is unduly influenced by China.

George Zixiang Zhou closely follows China's vaccine development in his role as policy and advocacy association at the Beijing-based consultancy Bridge Consulting. He joins Eric & Cobus from the Chinese capital to discuss what the Covax decision means for Beijing's COVID-19 vaccine strategy in Africa and why this is such a high-risk, high-reward undertaking.

JOIN THE DISCUSSION:

Facebook: www.facebook.com/ChinaAfricaProject

Twitter: @eolander | @stadenesque

SUBSCRIBE TO THE CAP'S DAILY EMAIL NEWSLETTER FOR JUST $3 FOR 3 MONTHS.

Your subscription supports independent journalism. Subscribers get the following:

1. A daily email newsletter of the top China-Africa news.

2. Access to the China-Africa Experts Network

3. Unlimited access to the CAP's exclusive analysis content on chinaafricaproject.com

Try it out for just $3 for 3 months: www.chinaafricaproject.com/subscribe

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  continue reading

298 episod

Artwork
iconKongsi
 
Manage episode 274340056 series 2776077
Kandungan disediakan oleh The China-Global South Project. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The China-Global South Project atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Last May, Chinese President Xi Jinping announced that Beijing would make any future COVID-19 vaccine available to Africa and other developing regions as a "global public good." He didn't explain, though, what that actually meant. Since that speech to the World Health Assembly, there've been very few details as to how China plans to distribute a C19 vaccine in Africa, how much it will cost and which countries will have to pay for it.

But last week we got our first clue as to what the Chinese may be planning to do. After months of hesitation, Chinese Foreign Ministry spokeswoman Hua Chunyin delivered a surprise announcement last Friday that the government will join the COVID-19 global vaccine alliance known as Covax. This is the same organization that the U.S. has refused to support due to its close relationship with the World Health Organization that Washington recently withdrew from and that it contends is unduly influenced by China.

George Zixiang Zhou closely follows China's vaccine development in his role as policy and advocacy association at the Beijing-based consultancy Bridge Consulting. He joins Eric & Cobus from the Chinese capital to discuss what the Covax decision means for Beijing's COVID-19 vaccine strategy in Africa and why this is such a high-risk, high-reward undertaking.

JOIN THE DISCUSSION:

Facebook: www.facebook.com/ChinaAfricaProject

Twitter: @eolander | @stadenesque

SUBSCRIBE TO THE CAP'S DAILY EMAIL NEWSLETTER FOR JUST $3 FOR 3 MONTHS.

Your subscription supports independent journalism. Subscribers get the following:

1. A daily email newsletter of the top China-Africa news.

2. Access to the China-Africa Experts Network

3. Unlimited access to the CAP's exclusive analysis content on chinaafricaproject.com

Try it out for just $3 for 3 months: www.chinaafricaproject.com/subscribe

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  continue reading

298 episod

Semua episod

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas